CULLINAN THERAPEUTICS INC (CGEM)
US2300311063 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 98.43M | 156.20M | 59.80M | 168.20M | 63.30M | |||
| Marketable Securities | 368.63M | 311.10M | 230.70M | 42.00M | 35.40M | |||
| Other Current Assets | 13.12M | 7.20M | 6.10M | 2.10M | 1.50M | |||
| Total Current Assets | 480.19M | 474.50M | 296.60M | 212.30M | 100.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.53M | 5.30M | 100.00K | 100.00K | 200.00K | |||
| Investments And Advances | 0.00 | 80.90M | 140.40M | N/A | N/A | |||
| Other Non-Current Assets | 459.00K | 500.00K | 100.00K | 2.30M | 200.00K | |||
| Total Non-Current Assets | 3.99M | 86.60M | 140.60M | 2.40M | 400.00K | |||
| TOTAL ASSETS | 484.18M | 561.10M | 437.20M | 214.70M | 100.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 200.00K | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 25.64M | 15.40M | 8.60M | 4.60M | 1.60M | |||
| Accounts Payable | 2.49M | 2.70M | 3.20M | 9.70M | 900.00K | |||
| Other Current Liabilities | 0.00 | 4.30M | N/A | 0.00 | 0.00 | |||
| Total Current Liabilities | 28.14M | 22.50M | 11.70M | 14.30M | 2.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.15M | 3.60M | 100.00K | 100.00K | 100.00K | |||
| Total Non-Current Liabilities | 2.34M | 3.60M | 500.00K | 1.40M | 1.00M | |||
| TOTAL LIABILITIES | 30.48M | 26.10M | 12.20M | 15.70M | 3.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -200.86M | -47.70M | -158.90M | -93.30M | -41.50M | |||
| Additional Paid In Capital | 654.68M | 585.30M | 584.70M | 15.70M | 800.00K | |||
| Minority Interest | 2.13M | 2.02M | 2.32M | 8.96M | 1.90M | |||
| Common Shares | 4.00K | 0.00 | 0.00 | 276.60M | 137.80M | |||
| Other Shareholders' Equity | -129.00K | -2.60M | -800.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 42.90M | 45.80M | 44.30M | 41.40M | 39.50M | |||
| Tangible Book Value per Share | 10.58 | 11.68 | 9.59 | -1.87 | -1.03 | |||
| Total Shareholders' Equity | 453.70M | 535.00M | 425.00M | 199.00M | 97.00M | |||
| TOTAL LIABILITIES AND EQUITY | 484.18M | 561.10M | 437.20M | 214.70M | 100.50M | |||
| Statistics | ||||||||
| Current Ratio | 17.07 | 21.09 | 25.35 | 14.85 | 40.04 | |||
| Return On Assets (ROA) | -31.63% | 19.82% | -15.00% | -24.13% | -20.56% | |||
| Return On Equity (ROE) | -33.76% | 20.79% | -15.43% | -26.03% | -21.30% | |||
All data in USD